Judith Goldberg
#89,508
Most Influential Person Now
American epidemiologist
Judith Goldberg's AcademicInfluence.com Rankings
Judith Goldbergmedical Degrees
Medical
#1609
World Rank
#1967
Historical Rank
#406
USA Rank
Epidemiology
#575
World Rank
#599
Historical Rank
#82
USA Rank
Download Badge
Medical
Judith Goldberg's Degrees
- Bachelors Biology University of California, Berkeley
- PhD Epidemiology Johns Hopkins University
Similar Degrees You Can Earn
Why Is Judith Goldberg Influential?
(Suggest an Edit or Addition)According to Wikipedia, Judith D. Goldberg is an American biostatistician and a professor in the New York University Grossman School of Medicine. Her research interests include the statistics of medical tests used for screening and medical diagnosis, clinical trials, and observational studies.
Judith Goldberg's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Psychosocial influences on mortality after myocardial infarction. (1984) (830)
- Applied Survival Analysis (1999) (669)
- Ventricular premature beats and mortality after myocardial infarction. (1977) (637)
- Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols. (1986) (512)
- Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial. (2015) (496)
- Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy. (1981) (479)
- Ischemic mitral valve reconstruction and replacement: comparison of long-term survival and complications. (2001) (327)
- Ventricular Premature Complexes and Sudden Death After Myocardial Infarction (1981) (324)
- A hypoxia-controlled cap-dependent to cap-independent translation switch in breast cancer. (2007) (273)
- Prone accelerated partial breast irradiation after breast-conserving surgery: preliminary clinical results and dose-volume histogram analysis. (2004) (235)
- Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer (2009) (233)
- Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast Cancer (2012) (184)
- Intravoxel incoherent motion imaging of tumor microenvironment in locally advanced breast cancer (2011) (184)
- Adverse effects of antiaggregating platelet therapy in the treatment of polycythemia vera. (1986) (178)
- Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas. (2014) (168)
- Phase I-II trial of prone accelerated intensity modulated radiation therapy to the breast to optimally spare normal tissue. (2007) (164)
- Focal Irradiation and Systemic TGFβ Blockade in Metastatic Breast Cancer (2018) (163)
- Prone vs supine positioning for breast cancer radiotherapy. (2012) (150)
- A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide. (1994) (148)
- Anastomotic strictures following radical prostatectomy: insights into incidence, effectiveness of intervention, effect on continence, and factors predisposing to occurrence. (2001) (144)
- Histologic features are important prognostic indicators in early stages lung adenocarcinomas (2007) (143)
- Phase II trial of lapatinib in adult and pediatric patients with neurofibromatosis type 2 and progressive vestibular schwannomas. (2012) (140)
- The Effects of Misclassification on the Bias in the Difference Between Two Proportions and the Relative Odds in the Fourfold Table (1975) (133)
- MPD-RC 101 prospective study of reduced-intensity allogeneic hematopoietic stem cell transplantation in patients with myelofibrosis. (2014) (132)
- Long-term management of polycythemia vera with hydroxyurea: a progress report. (1986) (131)
- Prospective assessment of optimal individual position (prone versus supine) for breast radiotherapy: volumetric and dosimetric correlations in 100 patients. (2012) (130)
- Dexmedetomidine for Awake Carotid Endarterectomy: Efficacy, Hemodynamic Profile, and Side Effects (2004) (127)
- Relation of education to sudden death after myocardial infarction. (1978) (122)
- Outcomes of the RESTOR-MV Trial (Randomized Evaluation of a Surgical Treatment for Off-Pump Repair of the Mitral Valve). (2010) (120)
- Corticotropin versus hydrocortisone in the intravenous treatment of ulcerative colitis: A prospective, randomized, double-blind clinical trial (1983) (108)
- Quality of life and behavioral follow-up study of pediatric survivors of craniopharyngioma. (2005) (107)
- Improved chemotherapy for ovarian cancer with cis‐diamminedichloroplatinum and adriamycin (1981) (103)
- Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO Stages III and IV) as measured by surgical end-staging (second-look operation). (1983) (103)
- Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosing (2019) (101)
- Pegylated Interferon Alfa-2a for Polycythemia Vera or Essential Thrombocythemia Resistant or Intolerant to Hydroxyurea. (2019) (99)
- Phase II study of everolimus in children and adults with neurofibromatosis type 2 and progressive vestibular schwannomas. (2014) (88)
- Prone accelerated partial breast irradiation after breast-conserving surgery: five-year results of 100 patients. (2012) (87)
- Treatment of polycythemia vera with hydroxyurea (1984) (85)
- Risk factors for postoperative recurrence of Crohn's disease. (1983) (84)
- Preoperative concurrent paclitaxel-radiation in locally advanced breast cancer: pathologic response correlates with five-year overall survival (2010) (83)
- Granulomas do not affect postoperative recurrence rates in Crohn's disease. (1982) (82)
- Helicobacter pylori and overweight status in the United States: data from the Third National Health and Nutrition Examination Survey. (2005) (81)
- Intrauterine intravascular transfusions for severe red blood cell isoimmunization: ultrasound-guided percutaneous approach. (1986) (81)
- Survival in familial dysautonomia: Impact of early intervention. (2002) (78)
- Characterization of the TGF-β1 signaling abnormalities in the Gata1low mouse model of myelofibrosis. (2013) (78)
- A panoramic view of the skull base: systematic review of open and endoscopic endonasal approaches to four tumors (2014) (77)
- A phase I study of panobinostat (LBH589) in patients with primary myelofibrosis (PMF) and post‐polycythaemia vera/essential thrombocythaemia myelofibrosis (post‐PV/ET MF) (2013) (76)
- Endothelin Receptor Type B Gene Promoter Hypermethylation in Salivary Rinses Is Independently Associated with Risk of Oral Cavity Cancer and Premalignancy (2010) (73)
- Resiquimod as an Immunologic Adjuvant for NY-ESO-1 Protein Vaccination in Patients with High-Risk Melanoma (2015) (72)
- Association of monocytic leukemia in patients with extreme leukocytosis. (1980) (72)
- EDNRB and DCC Salivary Rinse Hypermethylation Has a Similar Performance as Expert Clinical Examination in Discrimination of Oral Cancer/Dysplasia versus Benign Lesions (2013) (72)
- Ventricular Premature Complexes in Prognosis of Angina (1980) (70)
- Phase 2 trial of everolimus and carboplatin combination in patients with triple negative metastatic breast cancer (2014) (68)
- Incidence and outcome of chromosomal mosaicism found at the time of chorionic villus sampling. (1997) (66)
- The nonpredictive value of fetal urinary electrolytes: preliminary report of outcomes and correlations with pathologic diagnosis. (1987) (65)
- Mortality after first myocardial infarction. Search for a secular trend. (1982) (59)
- Central nervous system involvement at presentation in acute granulocytic leukemia. A prospective cytocentrifuge study. (1980) (59)
- Survival after surgery in stage IA and IB non-small cell lung cancer. (2008) (59)
- High levels of Hsp90 cochaperone p23 promote tumor progression and poor prognosis in breast cancer by increasing lymph node metastases and drug resistance. (2010) (59)
- Lipocalin produced by myelofibrosis cells affects the fate of both hematopoietic and marrow microenvironmental cells. (2015) (58)
- Gestational diabetes: impact of home glucose monitoring on neonatal birth weight. (1986) (58)
- Lack of major involvement of human uroplakin genes in vesicoureteral reflux: implications for disease heterogeneity. (2004) (54)
- Prone hypofractionated whole-breast radiotherapy without a boost to the tumor bed: comparable toxicity of IMRT versus a 3D conformal technique. (2012) (54)
- Surveillance Epidemiology and End Results Analysis Demonstrates Improvement in Overall Survival for Cervical Cancer Patients Treated in the Era of Concurrent Chemoradiotherapy (2015) (54)
- Matrix metalloproteinase-2 conditions human dendritic cells to prime inflammatory T(H)2 cells via an IL-12- and OX40L-dependent pathway. (2011) (54)
- The estimation of false negatives in medical screening. (1978) (52)
- Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant Chemotherapy. (2016) (50)
- Safety and efficacy of combined ruxolitinib and decitabine in accelerated and blast-phase myeloproliferative neoplasms. (2018) (47)
- Interstitial fluid pressure correlates with intravoxel incoherent motion imaging metrics in a mouse mammary carcinoma model (2012) (47)
- Late effects in survivors of childhood CNS tumors treated on Head Start I and II protocols (2014) (46)
- Association of MDM2 SNP309, Age of Onset, and Gender in Cutaneous Melanoma (2009) (45)
- Proactive Approach to Lymphedema Risk Reduction: A Prospective Study (2014) (44)
- Developing a multidisciplinary prospective melanoma biospecimen repository to advance translational research. (2009) (43)
- Repeated 1 hour electrocardiographic monitoring of survivors of myocardial infarction at 6 month intervals: arrhythmia detection and relation to prognosis. (1981) (42)
- The Importance of End-Systole for Optimal Reconstruction Protocol of Coronary Angiography With 16-Slice Multidetector Computed Tomography (2005) (42)
- Identification of an autoantibody panel to separate lung cancer from smokers and nonsmokers (2010) (42)
- Results of the Myeloproliferative Neoplasms - Research Consortium (MPN-RC) 112 Randomized Trial of Pegylated Interferon Alfa-2a (PEG) Versus Hydroxyurea (HU) Therapy for the Treatment of High Risk Polycythemia Vera (PV) and High Risk Essential Thrombocythemia (ET) (2018) (41)
- Intracarotid dehydrocholate infusion: a new method for prolonged reversible blood-brain barrier disruption. (1983) (41)
- Relation of carotid plaque with natural IgM antibodies in patients with systemic lupus erythematosus. (2014) (40)
- The use of cimetidine for the treatment of pruritus in polycythemia vera. (1982) (40)
- Outcomes of coronary artery bypass grafting and reduction annuloplasty for functional ischemic mitral regurgitation: a prospective multicenter study (Randomized Evaluation of a Surgical Treatment for Off-Pump Repair of the Mitral Valve). (2011) (39)
- Influence of therapy on causes of death in polycythemia vera. (1981) (39)
- Prone breast intensity modulated radiation therapy: 5-year results. (2014) (39)
- Acceptability of chorionic villi sampling for prenatal diagnosis. (1986) (38)
- Ruxolitinib Therapy Followed by Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation for Myelofibrosis: Myeloproliferative Disorders Research Consortium 114 Study. (2019) (38)
- Cisplatin regimens and improved prognosis of patients with poorly differentiated ovarian cancer. (1983) (37)
- Impact of Socioeconomic Status and Sociodemographic Factors on Melanoma Presentation Among Ethnic Minorities (2011) (37)
- Prognostic value of one hour of ECG monitoring of men with coronary heart disease. (1976) (37)
- CT Scan Screening for Lung Cancer: Risk Factors for Nodules and Malignancy in a High-Risk Urban Cohort (2012) (35)
- The effects of outcome misclassification and measurement error on the design and analysis of therapeutic equivalence trials (2001) (34)
- A Multicenter, Open Label Phase I/II Study of CEP701 (Lestaurtinib) in Adults with Myelofibrosis; a Report On Phase I: A Study of the Myeloproliferative Disorders Research Consortium (MPD-RC). (2009) (34)
- Evaluating Academic Scientists Collaborating in Team-Based Research: A Proposed Framework. (2015) (34)
- Kinetin in Familial Dysautonomia Carriers: Implications for a New Therapeutic Strategy Targeting mRNA Splicing (2009) (33)
- Corticotropin versus hydrocortisone in the intravenous treatment of ulcerative colitis. A prospective, randomized, double-blind clinical trial. (1983) (33)
- Education, psychosocial stress and sudden cardiac death. (1983) (33)
- PP6C Hotspot Mutations in Melanoma Display Sensitivity to Aurora Kinase Inhibition (2013) (32)
- Intravascular transfusion in utero: the percutaneous approach. (1986) (32)
- Detection of viral deoxyribonucleic acid in the amniotic fluid of low-risk pregnancies by polymerase chain reaction. (1995) (30)
- Baseline T cell dysfunction by single cell network profiling in metastatic breast cancer patients (2019) (29)
- Treatment of anemia in myeloproliferative disorders: a randomized study of fluoxymesterone v transfusions only. (1982) (29)
- Phase II study of irinotecan in combination with bevacizumab in recurrent ovarian cancer. (2017) (28)
- S-adenosylmethionine as a biomarker for the early detection of lung cancer. (2007) (27)
- Lung-specific expression of dominant-negative mutant p53 in transgenic mice increases spontaneous and benzo(a)pyrene-induced lung cancer. (2002) (27)
- Meta‐Analysis to Assess the Appropriate Endpoint for Slow Pathway Ablation of Atrioventricular Nodal Reentrant Tachycardia (2011) (27)
- Cell cycle features of C. elegans germline stem/progenitor cells vary temporally and spatially. (2016) (27)
- A Phase I Study of LBH589, a Novel Histone Deacetylase Inhibitor in Patients with Primary Myelofibrosis (PMF) and Post-Polycythemia/Essential Thrombocythemia Myelofibrosis (Post-PV/ET MF). (2009) (25)
- Impaired Humoral Immunity to SARS-CoV-2 Vaccination in Non-Hodgkin Lymphoma and CLL Patients (2021) (25)
- Folic acid and pregnancy. (1995) (25)
- Risk of malignancy in follicular neoplasms without nuclear atypia: statistical analysis of 397 thyroidectomies. (2003) (24)
- Phase I dose escalation study of lestaurtinib in patients with myelofibrosis (2015) (24)
- Ventricular Premature Beats and Mortality of Men with Coronary Heart Disease (1975) (24)
- Gene profiling of normal human bronchial epithelial cells in response to asbestos and benzo(a)pyrene diol epoxide (BPDE). (2007) (24)
- A phase II study of panobinostat in patients with primary myelofibrosis (PMF) and post-polycythemia vera/essential thrombocythemia myelofibrosis (post-PV/ET MF). (2017) (24)
- Three-year postoperative ultrasensitive prostate-specific antigen following open radical retropubic prostatectomy is a predictor for delayed biochemical recurrence. (2011) (23)
- Inflammatory cytokines and non-small cell lung cancer in a CT-scan screening cohort: Background review of the literature. (2016) (22)
- Importance of MR technique for stereotactic radiosurgery. (2003) (21)
- Natalizumab Extended Interval Dosing Is Associated with a Reduction in Progressive Multifocal Leukoencephalopathy (PML) Risk in the Touch® Registry (2018) (21)
- Studying Physician Knowledge, Attitudes, and Practices Regarding the Herpes Zoster Vaccine to Address Perceived Barriers to Vaccination (2013) (21)
- A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia (2022) (21)
- Increased prevalence of polycythemia vera in parents of patients on polycythemia vera study group protocols (1984) (21)
- The Young Women's Program: A health and wellness model to empower adolescents with physical disabilities. (2010) (20)
- Phase I/II study of single‐agent bortezomib for the treatment of patients with myelofibrosis. Clinical and biological effects of proteasome inhibition (2010) (19)
- Prospective Randomized Trial of Prone Accelerated Intensity Modulated Breast Radiation Therapy With a Daily Versus Weekly Boost to the Tumor Bed. (2016) (19)
- The importance of location in determining breast conservation rates. (2005) (19)
- Antenatal diagnosis of recessive dystrophic epidermolysis bullosa: collagenase expression in cultured fibroblasts as a biochemical marker. (1986) (18)
- 54: External Beam Partial Breast Irradiation Following Breast-Conserving Surgery: Preliminary Results of Cosmetic Outcome of NYU 00-23 (2006) (18)
- CISPLATIN THERAPY OF OVARIAN CANCER (1980) (18)
- Prolonged Low Dose Therapy with a Pan-Deacetylase Inhibtor, Panobinostat (LBH589), in Patients with Myelofibrosis (2011) (17)
- Topical TLR 7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast Cancer (2012) (17)
- Pharmacodynamics of natalizumab extended interval dosing in MS (2020) (17)
- Pembrolizumab (pembro) in combination with gemcitabine (Gem) and concurrent hypofractionated radiation therapy (RT) as bladder sparing treatment for muscle-invasive urothelial cancer of the bladder (MIBC): A multicenter phase 2 trial. (2021) (17)
- A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis (2019) (16)
- Effect of intracarotid etoposide on opening the blood-brain barrier. (1984) (16)
- Examining nurses' decision process for medication management in home care. (2005) (16)
- American College of Medical Genetics statement on folic acid: fortification and supplementation. (1998) (16)
- Origin and length of left main coronary artery: its relation to height, weight, sex, age, pattern of coronary distribution, and presence or absence of coronary artery disease. (1978) (15)
- Clonal analyses define the relationships between chromosomal abnormalities and JAK2V617F in patients with Ph-negative myeloproliferative neoplasms. (2009) (15)
- Role of opsonins in clinical response to granulocyte transfusion in granulocytopenic patients. (1982) (15)
- Chemotherapy versus chemoimmunotherapy with levamisole or Corynebacterium parvum in advanced lung cancer. (1982) (15)
- Serial immunological parameters in a phase II trial of exemestane and low-dose oral cyclophosphamide in advanced hormone receptor-positive breast cancer (2018) (14)
- Evaluation of pro-carboxypeptidase A and carboxypeptidase A as serologic markers for adenocarcinoma of the pancreas. (2006) (13)
- Levels of elevated circulating endothelial cell decline after tumor resection in patients with pancreatic ductal adenocarcinoma. (2010) (13)
- 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts (2016) (12)
- Gestational diabetes: Impact of home glucose monitoring on neonatal birth weight (1987) (12)
- Prenatal prediction of osteogenesis imperfecta (OI type IV): exclusion of inheritance using a collagen gene probe. (1987) (12)
- Increasing use of the vaccine against zoster through recommendation and administration by ophthalmologists at a city hospital. (2013) (12)
- Single agent bevacizumab for myelofibrosis: results of the Myeloproliferative Disorders Research Consortium Trial (2013) (12)
- Fludrocortisone in patients with familial dysautonomia--assessing effect on clinical parameters and gene expression. (2005) (12)
- Phase II trial of Lestaurtinib, a JAK2 inhibitor, in patients with myelofibrosis (2019) (12)
- Results of Phase II Clinical Trial MPD-RC 101: Allogeneic Hematopoietic Stem Cell Transplantation Conditioned with Fludarabine/Melphalan in Patients with Myelofibrosis (2011) (12)
- Immunohistochemical study of fibrosis and adenocarcinoma in dominant-negative p53 transgenic mice exposed to chrysotile asbestos and benzo(a)pyrene. (2008) (12)
- Phase I-II study of prone accelerated partial breast irradiation (2004) (11)
- Carcinoma of the breast: interrelationships among histopathologic features, estrogen receptor activity, and age of the patient. (1983) (11)
- Plasma Zonulin Levels in Childhood Nephrotic Syndrome (2019) (11)
- Improving Adherence to National Recommendations for Zoster Vaccination Through Simple Interventions (2014) (11)
- Preplanning prediction of the left anterior descending artery maximum dose based on patient, dosimetric, and treatment planning parameters (2016) (10)
- Filtration versus gravity leukapheresis in febrile granulocytopenic patients: a randomized prospective trial. (1981) (10)
- Randomized Controlled Trial of Quinacrine for the Treatment of HBsAg‐Positive Chronic Hepatitis (2007) (10)
- Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO III and IV) as measured by surgical end-staging (second-look surgery)--the mount sinai experience. (1983) (10)
- Hypofractionated Whole-Breast Irradiation in Women Less Than 50 Years Old Treated on 4 Prospective Protocols. (2018) (10)
- Fludrocortisone in patients with familial dysautonomia (2005) (10)
- IKBKAP mRNA in Peripheral Blood Leukocytes: A Molecular Marker of Gene Expression and Splicing in Familial Dysautonomia (2008) (10)
- Results of a phase I–II study of adjuvant concurrent carboplatin and accelerated radiotherapy for triple negative breast cancer (2017) (10)
- A hybrid Bayesian‐frequentist approach to evaluate clinical trial designs for tests of superiority and non‐inferiority (2008) (10)
- Pilot Trial of Radiation Therapy and GM-CSF in Metastatic Cancer: Abscopal Responses (2012) (9)
- The Evaluation of Medical Screening Procedures (1981) (9)
- Single-Arm Salvage Therapy with Pegylated Interferon Alfa-2a for Patients with High-Risk Polycythemia Vera or High-Risk Essential Thrombocythemia Who Are Either Hydroxyurea-Resistant or Intolerant: Final Results of the Myeloproliferative Disorders-Research Consortium (MPD-RC) Protocol 111 Global Pha (2017) (8)
- Comparison of the immunogenicity of Montanide ISA 51 adjuvant and cytokine-matured dendritic cells in a randomized controlled clinical trial of melanoma vaccines. (2009) (8)
- Clinical trial evidence of the antitumor activity of topical imiquimod for breast cancer skin metastases. (2014) (8)
- Designing and Implementing INTREPID, an Intensive Program in Translational Research Methodologies for New Investigators (2014) (7)
- Plasma osteopontin velocity differentiates lung cancers from controls in a CT screening population. (2012) (7)
- Quality of Life in Women Undergoing Breast Irradiation in a Randomized, Controlled Clinical Trial Evaluating Different Tumor Bed Boost Fractionations. (2016) (6)
- Exploring the Utility of Automated Drug Alerts in Home Healthcare (2006) (6)
- Sudden death after myocardial infarction: Runs of ventricular premature beats and R on T as high risk factors (1980) (6)
- 071 Natalizumab extended interval dosing (EID) is associated with a significant reduction in progressive multifocal leukoencephalopathy (PML) risk compared with standard interval dosing (SID) in the touch® prescribing program (2018) (6)
- Serum albumin at 1 year predicts long-term renal outcome in lupus nephritis (2018) (6)
- Multifocal Invasive Ductal Cancer: Distinguishing Independent Tumor Foci From Multiple Satellites (2017) (5)
- Design of clinical trials for chronic diseases: implications for periodontal disease. (1986) (5)
- A prospective trial to compare deep inspiratory breath hold (DIBH) with prone breast irradiation. (2020) (5)
- Prospective Trial of Individual Optimal Positioning (Prone Versus Supine) for Whole Breast Radiotherapy: Results of the First 168 Patients (2007) (5)
- Phase II trial of pembrolizumab in combination with nab-paclitaxel in patients with metastatic HER2-negative breast cancer. (2017) (5)
- Phase 0 Clinical Trial of Everolimus in Patients with Vestibular Schwannoma or Meningioma (2021) (4)
- Evaluation of plasma osteopontin as early detection and prognostic marker in malignant pleural mesothelioma (2008) (4)
- First prospective study of allogeneic peripheral blood stem cell (PBSC) transplantation in patients with myelofibrosis in the United States: Interim analysis of MPD-RC 101 protocol. (2010) (4)
- Hypo-fractionated partial breast radiation after breast-conserving surgery: preliminary clinical results and dose volume histogram (DVH) analysis (2003) (4)
- Quantifying sociodemographic and income disparities in medical therapy and lifestyle among symptomatic patients with suspected coronary artery disease: a cross-sectional study in North America (2017) (4)
- The importance of karyotype determination in a fetus with ventriculomegaly and spina bifida discovered during the third trimester. (1986) (4)
- Adherence to guidelines at the patient‐ and hospital‐levels is associated with improved overall survival in patients with gastric cancer (2022) (4)
- Rationale, study design and implementation of the LUCINDA Trial: Leuprolide plus cholinesterase inhibition to reduce neurologic decline in Alzheimer's. (2021) (4)
- OUTCOMES OF THE RANDOMIZED EVALUATION OF A SURGICAL TREATMENT FOR OFF-PUMP REPAIR OF THE MITRAL VALVE (RESTOR-MV) TRIAL (2010) (4)
- Neoadjuvant therapy of gastric cancer with cetuximab added to both irinotecan and cisplatin, followed by surgical resection and adjuvant chemoradiation. (2009) (4)
- Developing a Consensus Framework and Risk Profile for Agents of Opportunity in Academic Medical Centers: Implications for Public Health Preparedness (2010) (3)
- Design and Analysis of Multicenter Trials (2016) (3)
- ATIM-37. PHASE II, OPEN-LABEL, SINGLE ARM, MULTICENTER STUDY OF AVELUMAB WITH HYPOFRACTIONATED RADIATION (HFRT) FOR ADULT PATIENTS WITH SECONDARILY TRANSFORMED IDH-MUTANT GLIOBLASTOMA (GBM) (2019) (3)
- A phase I/II multisite study of nivolumab and carboplatin/paclitaxel with radiation therapy (RT) in patients with locally advanced esophageal squamous cell carcinoma (ESCC). (2018) (3)
- Characteristics of ventricular premature beats and prognosis of men with coronary heart disease (1976) (3)
- Efficacy of RAD001/carboplatin in triple-negative metastatic breast cancer: A phase II study. (2012) (3)
- Value of metalloproteinases in predicting COPD in heavy urban smokers (2020) (3)
- Cesarean Section Indication and the Risk of Respiratory Distress Syndrome (1981) (3)
- Novel Combination of Toll-Like Receptor (TLR)-7 Agonist Imiquimod and Local Radiation Therapy in the Treatment of Metastatic Breast Cancer Involving the Skin or Chest Wall (2013) (3)
- A Note on Monotonicity Assumptions for Exact Unconditional Tests in Binary Matched‐Pairs Designs (2011) (2)
- Natalizumab extended interval dosing (EID) is associated with a significant reduction in progressive multifocal leukoencephalopathy (PML) risk compared with standard interval dosing (SID) in the TOUCH® Prescribing Program (2019) (2)
- Abstract P5-20-05: A Phase 2 trial of RAD 001 and Carboplatin in patients with triple negative metastatic breast cancer (2012) (2)
- Natalizumab extended interval dosing (EID) is associated with a reduced risk of progressive multifocal leukoencephalopathy (PML) than every-4-week (Q4W) dosing: Updated analysis of the TOUCH® Prescribing Program database (1988) (2020) (2)
- A Prospective Trial to Compare Deep Inspiratory Breath Hold (DIBH) with Prone Breast Irradiation (2018) (2)
- A phase II trial on the combination of bevacizumab and irinotecan in recurrent ovarian cancer. (2014) (2)
- Elevated Levels of Urinary Biomarkers TIMP-2 and IGFBP-7 Predict Acute Kidney Injury in Neonates after Congenital Heart Surgery (2022) (2)
- NFB-08. PHASE II STUDY OF AXITINIB IN PATIENTS WITH NEUROFIBROMATOSIS TYPE 2 AND PROGRESSIVE VESTIBULAR SCHWANNOMAS (2020) (2)
- A Phase I Study of the Proteasome Inhibitor Bortezomib in Patients with Myelofibrosis. (2007) (2)
- Resistance to therapy of acute leukemia developing in the course of polycythemia vera. (1981) (2)
- HEMATOPOIESIS AND STEM CELLS Characterization of the TGF-b 1 signaling abnormalities in the Gata 1 low mouse model of myelo fi brosis (2013) (2)
- Prognosis of men after first acute myocardial infarction in the 1960's and 1970's: Search for a secular trend (1981) (2)
- Randomized Trial of Prone Accelerated Whole-Breast Radiation Therapy With a Daily Versus Weekly Boost to the Tumor Bed: Acute Toxicity and Associated Dosimetry (2015) (2)
- A phase II feasibility study of nab-paclitaxel and carboplatin in chemotherapy naïve epithelial neoplasms of the uterus (2019) (2)
- Association of MDM 2 SNP 309 , Age of Onset , and Gender in CutaneousMelanoma (2009) (2)
- Pretreatment marrow cytogenetic status: a predictor of response to remission induction therapy in acute myelogenous leukemia. (1983) (2)
- Comparison of Clinical Measures Among Interstitial Lung Disease (ILD) Patients with Usual Interstitial Pneumonia (UIP) Patterns on High-Resolution Computed Tomography (2020) (2)
- RAD001-carboplatin combination in triple-negative metastatic breast cancer (TNMBC): A phase II trial. (2013) (2)
- Lymphatic and proinflammatory candidate gene variations and lymphedema. (2013) (2)
- NYU 03-30: Accelerated IMRT with Concomitant Boost after Breast Conservation Surgery. Preliminary Clinical Results in 70 Patients (2005) (1)
- Novel combination of toll-like receptor (TLR)-7 agonist imiquimod and local radiotherapy in the treatment of breast cancer chest wall recurrences or skin metastases. (2013) (1)
- Evaluation of toll-like receptor (TLR)-7 agonist imiquimod applied topically to breast cancer chest wall recurrences or skin metastases. (2010) (1)
- Study designs for evaluating antihypertensive drugs as both single and supplemental agents (1985) (1)
- Phase II trial of irinotecan plus bevacizumab for heavily pretreated recurrent ovarian cancer. (2012) (1)
- Intent-to-Treat Principle† (2014) (1)
- Prone accelerated partial breast irradiation (five fractions) after breast conservation therapy with heart and lung sparing. (2004) (1)
- Five-year results of preoperative concurrent paclitaxel with radiation in locally advanced breast cancer (LABC). (2010) (1)
- Abstract OT2-1-02: Novel combination of toll-like receptor (TLR)-7 agonist imiquimod and local radiotherapy in the treatment of breast cancer chest wall recurrences or skin metastases (2013) (1)
- Toward strategies for the analysis of periodontal disease clinical trials. (1992) (1)
- Hyperactivated mTOR and JAK2/STAT3 pathways: Crucial molecular drivers and potential therapeutic targets of inflammatory breast cancer (IBC). (2013) (1)
- Agent of Opportunity Risk Mitigation: People, Engineering, and Security Efficacy (2010) (1)
- ACTH vs. hydrocortisone in ulcerative colitis. (1983) (1)
- Phase III Study Comparing Prone Accelerated Whole Breast IMRT with a Daily vs. a Weekly Tumor Bed Boost: Interim Analysis Results (2010) (1)
- A population-based, case-control study of MC1R variants, ultraviolet light exposure, and melanoma. (2011) (1)
- A Multi-Center Retrospective Review of COVID-19 Outcomes in Patients with Lymphoid Malignancy (2021) (1)
- Identification of tyrosinase polymorphisms for use in melanoma risk assessment. (2010) (1)
- Abstract 5639: Preoperative concurrent paclitaxel and radiation in locally advanced breast cancer (LABC): Five-year outcomes on 105 patients (2010) (1)
- Meta-Analysis in Clinical Risk Assessment† (2014) (1)
- Combination of irinotecan and bevacizumab for heavily pretreated recur- rent ovarian cancer: A phase II trial (2013) (1)
- S0520 The Napoleon: A Pilot Feasibility Study of a Small Endoscopic Ruler for Accurate Polyp Measurement (2020) (1)
- Reduced risk of progressive multifocal leukoencephalopathy (PML) associated with natalizumab extended interval dosing (EID): updated analysis of the TOUCH® Prescribing Program database (S26.006) (2019) (1)
- Cis-Platinum Trials for Gynecological Tumors (1980) (1)
- 129P Phase II study of pembrolizumab and nab-paclitaxel in HER2-negative metastatic breast cancer: Hormone receptor-positive cohort (2020) (1)
- Prospective Randomized Trial of Prone Accelerated Whole Breast Radiation Therapy With a Concurrent Daily Versus Weekly Boost to the Tumor Bed: Acute Toxicity (2012) (1)
- Delivery of adjuvant chemotherapy among stage III colon cancer patients at a public versus private hospital in New York City (2018) (1)
- [The Statistical Precision of Medical Screening Procedures: Application to Polygraph and AIDS Antibodies Test Data]: Comment (1987) (1)
- Intention to Treat and Alternative Approaches (2020) (1)
- Systematic Missing-At-Random (SMAR) Design and Analysis for Translational Research Studies (2008) (1)
- Prenatal shunting of fetal ascites in nonimmune hydrops fetalis. (1986) (1)
- P1-17-07: Phase II Trial of RAD001 Plus Carboplatin in Patients with Triple-Negative Metastatic Breast Cancer. (2011) (0)
- Abstract SY40-02: Interplay between microenvironment and cancers (2012) (0)
- THER-07. A PHASE 0 PHARMACODYNAMIC AND PHARMACOKINETIC STUDY OF EVEROLIMUS IN VESTIBULAR SCHWANNOMA (VS) AND MENINGIOMA PATIENTS (2019) (0)
- Phase I/II Study of Prone Accelerated IMRT to Treat the Breast, Level 3 Axilla, and Supraclavicular Nodes (2012) (0)
- Abstract P2-10-05: Lymphatic and pro-inflammatory candidate gene variations and breast-cancer related lymphedema (2013) (0)
- Predictors of pathologic response and correlation with long-term outcomes in a trial of neoadjuvant concurrent paclitaxel radiation in locally advanced breast cancer (LABC). (2010) (0)
- Prone accelerated partial breast irradiation (five fractions) after breast conservation therapy with heart and lung sparing (2004) (0)
- Five-year Results of Preoperative Paclitaxel with Concurrent Radiation Therapy in Locally Advanced Breast Cancer: Pathological Response Predicts for Survival (2010) (0)
- True Story Project: I Am Heard: Empowering Female Adolescents with Physical Disabilities through Creative Expression (2012) (0)
- MDM2 SNP309 and melanoma risk among women (2008) (0)
- Disparities in Time to Treatment ofHepatocellular Carcinoma in Patients withHepatitis B Virus versus Hepatitis C Virus (2017) (0)
- Abstract 5282: Comparison of a public versus private hospital in New York City in delivering timely adjuvant chemotherapy among stage III colon cancer patients (2017) (0)
- Lung Nodules And Patient Characteristics In A High Risk Lung Cancer Screening Cohort (2011) (0)
- Comparative Efficacy Trials (Phase III Studies) (2008) (0)
- Loss of nuclear p27KIP1 (p27) expression as a predictor of lymph node spread in T1 breast cancer. (2012) (0)
- Cytokines IP-10 and MCP-1 Are Potential Biomarkers for Early Detection of Lung Adenocarcinoma. (2009) (0)
- Abstract P2-11-11: Phase II trial of exemestane with immunomodulatory oral cyclophosphamide in metastatic hormone receptor (HR)-positive breast cancer: Prolonged progression-free survival (PFS) in patients with distinct T regulatory cell (Treg) profile (2016) (0)
- Post-Transplant Cyclophosphamide, Abatacept and Short Course of Tacrolimus (CAST) for Graft-Versus-Host Disease Prevention Following Haploidentical Peripheral Blood Stem Cell Transplantation (2022) (0)
- ' s response to reviews Title : Autoantibodies to Tumor Associated Antigens as Early Detection Biomarkers for Lung Cancer or Noncalcified Nodules (2009) (0)
- Phase II clinical and immune correlate study of adjuvant nivolumab plus ipilimumab for high-risk resected melanoma (2022) (0)
- Randomized Controlled Trials (2008) (0)
- Right ventricular and left ventricular diameters are independent predictors of death or cardiopulmonary resuscitation in intermediate and high-risk pulmonary embolisms (2022) (0)
- Correlation of Novel Molecular Markers in Patients with Myeloproliferative Neoplasms. (2009) (0)
- The LUCINDA trial: Leuprolide + cholinesterase inhibition to reduce neurologic decline in Alzheimer's (2020) (0)
- Intent-to-Treat Principle (2008) (0)
- Impact of population genetic substructure on association studies and risk assessment for melanoma. (2011) (0)
- Crohn's disease phenotype analysis with iodine density from dual-energy CT enterography. (2023) (0)
- Increasing coverage of a vaccine against herpes zoster at New York University Langone Medical Center and Bellevue Hospital (2012) (0)
- Phase 2 trial of everolimus and carboplatin combination in patients with triple negative metastatic breast cancer (2014) (0)
- Methylation profiling of locally advanced rectal cancer (LARC): Exploration of potential predictive markers for neoadjuvant chemoradiation (NACR). (2016) (0)
- Abnormal P-Selectin Localization During Megakaryocyte Development Determines Thrombosis in the Gata1low Model of Myelofibrosis. (2009) (0)
- Effect of mebendazole on melanoma xenograft growth through targeting of bcl-2. (2009) (0)
- Meta‐Analysis in Clinical Risk Assessment (2008) (0)
- Thrombopoietin Receptor (MPL) Genotype Modifies the Myeloproliferative Phenotype in a JAK2 V617F Transgenic Mouse Model of Polycythemia Vera. (2009) (0)
- Post-Transplant Cyclophosphamide, Abatacept, and Short Course of Tacrolimus Combination (CAST) Is Safe and Seems Highly Effective in Preventing Graft-Versus-Host Disease Following Haploidentical Peripheral Blood Stem Cell Transplantation (2021) (0)
- Developing genetic markers for melanoma risk assessment. (2009) (0)
- 1948 THREE YEAR POSTOPERATIVE PSA FOLLOWING OPEN RADICAL RETROPUBIC PROSTATECTOMY (ORRP) IS A PREDICTOR FOR DELAYED BIOCHEMICAL RECURRENCES (BCR) (2010) (0)
- PATTERNS OF PREVENTIVE MEDICAL THERAPY AND LIFESTYLE PRACTICES IN PATIENTS EVALUATED FOR SUSPECTED CORONARY ARTERY DISEASE: THE PROMISE TRIAL (PROSPECTIVE MULTICENTER IMAGING STUDY FOR EVALUATION OF CHEST PAIN) (2016) (0)
- Acknowledgment of Reviewers 2021. (2021) (0)
- Five-year Local Control Results of Preoperative Paclitaxel with Concurrent Radiation Therapy in Locally Advanced Breast Cancer (2010) (0)
- Lack of Hormone Receptor Expression is Associated with Pathological Response in Locally Advanced Breast Cancer Patients Treated with Neoadjuvant Concurrent Chemoradiation (2009) (0)
- Abstract P5-16-26: National trends in neoadjuvant therapy for breast cancer (2017) (0)
- Emphysema Diagnosed on CT-Scan Compared to Normal Smoker CT-Scan in Lung Cancer Screening Trials. (2009) (0)
- Concurrent adjuvant systemic therapy and accelerated radiotherapy in triple-negative breast cancer: A feasibility trial. (2014) (0)
- othelin Receptor Type B Gene Promoter Hypermethylation alivary Rinses Is Independently Associated with Pr R of Oral Cavity Cancer and Premalignancy (2010) (0)
- The Effects of Lipocalin (LCN2) on Hematopoiesis in Primary Myelofibrosis (2014) (0)
- Delivery of adjuvant chemotherapy among stage III colon cancer patients at a public versus private hospital in New York City (2017) (0)
- ACTR-09. A PHASE 0 PHARMACODYNAMIC AND PHARMACOKINETIC STUDY OF EVEROLIMUS IN VESTIBULAR SCHWANNOMA (VS) AND MENINGIOMA PATIENTS (2019) (0)
- Progression free survival (PFS) in Asian vs non-Asian patients (pts) with EGFR mutant non-small cell lung cancer (NSCLC) receiving osimertinib. (2020) (0)
- Abstract OT1-01-03: Impact of RANKL inhibition on tumor microenvironment of early-stage breast cancer, a pre-surgical trial (2020) (0)
- Evaluation of the melanocortin-1-receptor gene in melanoma predisposition, progression, and recurrence. (2009) (0)
- Post-Transplant High Dose Cyclophosphamide and Bortezomib As Graft-Versus-Host Disease Prophylaxis Following Allogeneic Hematopoietic Stem Cell Transplantation (2021) (0)
- 99 Para-amino benzoic acid (PABA) modulation of chemotherapy — evolution from preclinical work to a Phase I study. A report of early clinical activity including pharmacokinetic and pharmacodynamic studies (2004) (0)
- hat improve the q uality of life may yet be shown to extend the length of life as well. (2017) (0)
- Levels of Hsp 90 Cochaperone p 23 Promote Tumor gression and Poor Prognosis in Breast Cancer by R easing Lymph Node Metastases and Drug Resistance (2010) (0)
- A Phase I Study of Immune Checkpoint Inhibition (anti-CTLA4 and anti-PD-L1) in Combination with RadiationTherapy in Patients with Locally Advanced UnresectablePancreatic Cancer (2020) (0)
- Impact of socioeconomic status on melanoma clinical presentation and prognosis in non-White melanoma patients. (2010) (0)
- SAFETY OF CARDIAC REHABILITATION IN THE ACUTE POSTCORONARY STENT PERIOD (2000) (0)
- Plasma S-adenosylmethionine: A methyl donor as a potential aid in the diagnosis and treatment of colorectal cancer (2003) (0)
- Cytogenetic findings in the polycythemia vera: long-term follow-up in patients randomized to treatment by the Polycythemia Vera Study Group (1988) (0)
- Abstract PD5-6: Sustained hyperactivated mTOR & JAK2/STAT3 pathways in inflammatory breast cancer (IBC): Evidence for mTOR plus JAK2 therapeutic targeting (2013) (0)
- Toxicity (Adverse Events) (2008) (0)
- Pathologic response rate in HER2-positive locally advanced breast cancers treated with neoadjuvant trastuzumab and concurrent paclitaxel/radiotherapy. (2012) (0)
This paper list is powered by the following services:
Other Resources About Judith Goldberg
What Schools Are Affiliated With Judith Goldberg?
Judith Goldberg is affiliated with the following schools:
